Nano-X Imaging

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Neve Ilan, Israel.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nano-X Imaging reports progress in regulatory clearances and strategic partnerships

Nano-X Imaging showcased progress in regulatory clearances, commercialization efforts, strategic partnerships, and operational optimization during the Q4 2022 Earnings Call.
Despite challenges in regulatory compliance, expenses management, and market competition, the company's strengths in innovation, partnerships, and financial resilience position it well for future growth.
Opportunities for Nano-X Imaging include global expansion, technological advancements, cost efficiencies, and leveraging market demand for imaging solutions.
Overall, Nano-X Imaging's performance in Q4 2022 reflects a strategic focus on growth, innovation, and market expansion in the medical imaging industry.

Nano-X Imaging reports improved Q1 performance and expands global reach

Nano-X Imaging's Q1 2023 performance showed improvement with a reported net loss of $11.8 million and revenue of $2.4 million. The company is focusing on deploying Nanox.ARC globally, strengthening manufacturing capabilities, and expanding market reach through strategic partnerships. Challenges include managing expenses and driving revenue growth to achieve profitability.

Nanox Imaging reports Q2 results, eyes U.S. market growth

Nanox Imaging's Q2 2023 performance reflects investment in growth initiatives, with a focus on market expansion and product deployment.
The company faces financial challenges, including a significant net loss and accrued expenses related to an SEC investigation, necessitating prudent financial management.
Strategic strengths in the U.S. market entry, global commercialization efforts, and strong cash position position Nanox Imaging for future growth and market success.
Opportunities lie in upcoming Investor Day, FDA clearance for Nanox.ARC, and expansion in Africa, offering avenues for revenue growth and market leadership.

Nanox Imaging reports Q3 revenue growth and strategic advancements

Nanox Imaging's Q3 2023 performance showed revenue growth and strategic advancements. While facing financial challenges and potential execution hurdles, the company's focus on expansion and partnerships positions it for future growth.

Nanox Imaging reports Q4 loss, eyes global expansion and AI

Nanox Imaging's Q4 2023 performance showed a mix of revenue growth and strategic investments in technology and market expansion.
The company's strengths lie in its progress with regulatory clearances, commercialization efforts, and success in AI applications.
Challenges include slow AI adoption, implementation hurdles, and the need to overcome barriers to data sharing and transparency.
Opportunities exist in expanding HealthCCS usage, global market presence, and addressing AI adoption challenges for revenue growth.

Nanox Imaging reports Q1 loss, eyes global expansion and AI growth

Nanox Imaging's Q1 2024 performance reflects revenue generation from AI solutions and system sales amid challenges in gross profit margins and a notable net loss.
The company's strategic strengths in partnerships, product launches, and global expansions position it well for future growth and market competitiveness.
While facing challenges in cost management and profitability, Nanox Imaging holds opportunities in expanded indications, market expansions, and AI solutions deployment.

Nano-X Imaging reports Q2 losses, eyes growth through FDA clearances

Nano-X Imaging (NNOX) showcased progress in commercial and clinical fronts but faces challenges in narrowing losses and optimizing operations.
Strategic collaborations, FDA clearances, and global deployment offer opportunities for growth and market expansion.
The focus on transformative imaging solutions and commercial infrastructure acceleration underlines NNOX's commitment to innovation and market leadership.

Nanox Imaging reports mixed Q3 results amidst growth opportunities

Nanox Imaging reported mixed financial results with revenue of $3.0 million and a gross loss of $2.8 million, while achieving record revenue from USARAD business.
The company showcased strengths in technology deployment, partnerships, and clinical trials, but faces challenges in regulatory clearances and financial performance.
Opportunities exist in market expansion, revenue growth, and operational efficiency improvements to drive future success and profitability.
With a strong focus on innovation, partnerships, and market expansion, Nanox is poised for growth but needs to address regulatory hurdles and financial performance.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.

Boston Beer Company

NEW YORK, NY / ACCESSWIRE / October 28, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SAM, NNOX and RECAF

NEW YORK, Oct. 27, 2021 /PRNewswire/ -- WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between June 17, 2021 and August 18, 2021, inclusive (the "Class Period"), of the important December 6, 2021 lead plaintiff deadline.

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NNOX

Eargo

Innovage Holding Corp

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

SHAREHOLDER ALERT: EAR NNOX INNV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

HyreCar

NEW YORK, NY / ACCESSWIRE / October 25, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HYRE, EAR and NNOX

Katapult Holdings

Cassava Sciences Inc

NEW YORK, NY / ACCESSWIRE / October 21, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, SAVA and NNOX

Honest Co

Waterdrop

NEW YORK, NY / ACCESSWIRE / October 20, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of WDH, HNST and NNOX

New York, New York--(Newsfile Corp. - October 20, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between June 17, 2021 and August 18, 2021, inclusive (the "Class Period"), of the important December 6, 2021 lead plaintiff deadline.SO WHAT: If you purchased Nano-X securities during the Class Period you may be entitled to compensation without payment of any out of pocket...

SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NNOX

NEW YORK, NY / ACCESSWIRE / October 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAM, EAR and NNOX

Spectrum Pharma

NEW YORK, NY / ACCESSWIRE / October 18, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SPPI, NNOX and INNV

LOS ANGELES--(BUSINESS WIRE)---- $nnox #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 6, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) securities between June 17, 2021 and August 18, 2021, inclusive (the “Class Period”). If you suffered a loss on your Nano-X investments or would like to inquire about potentially pursuing c

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nano-X Imaging Ltd. (NNOX)

Hyzon Motors

NEW YORK, NY / ACCESSWIRE / October 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.

LAWSUITS FILED AGAINST SAM, HYZN and NNOX - Jakubowitz Law Pursues Shareholders Claims

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between June 17, 2021 and August 18, 2021, inclusive (the “Class Period”), of the important December 6, 2021 lead plaintiff deadline. SO WHAT: If you purchased Nano-X securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors With Losses to Secure Counsel Before Important December 6 Deadline in Securities Class Action – NNOX

NEW YORK, Oct. 15, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between June 17, 2021 and August 18, 2021, inclusive (the "Class Period"), of the important December 6, 2021 lead plaintiff deadline.

ROSEN, A LEADING LAW FIRM, Encourages Nano-X Imaging Ltd. Investors With Losses Over $100K to Secure Counsel Before Important December 6 Deadline in Securities Class Action - NNOX

LOS ANGELES--(BUSINESS WIRE)---- $NNOX #investors--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Nano-X Imaging Ltd. (NNOX) Investors

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Nano-X Imaging Ltd.

BENSALEM, Pa.--(BUSINESS WIRE)---- $nnox #CLASSACTION--Law Offices of Howard G. Smith reminds investors of the upcoming December 6, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) securities between June 17, 2021 and August 18, 2021, inclusive (the “Class Period”). Nano-X investors have until December 6, 2021 to file a lead plaintiff motion. Investors suffering losses on their Nano-X investments are enc

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nano-X Imaging Ltd.

NEW YORK, NY / ACCESSWIRE / October 14, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.

LAWSUITS FILED AGAINST SAM, WDH and NNOX - Jakubowitz Law Pursues Shareholders Claims

LOS ANGELES--(BUSINESS WIRE)---- $NNOX #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) securities between June 17, 2021 and August 18, 2021, inclusive (the “Class Period”). Nano-X investors have until December 6, 2021 to file a lead plaintiff motion. If you suffered a loss on your Nano-X inv

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Nano-X Imaging Ltd. (NNOX) Investors

ROSEN, A TOP RANKED LAW FIRM, Encourages Nano-X Imaging Ltd. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – NNOX

BENSALEM, Pa.--(BUSINESS WIRE)---- $nnox #CLASSACTION--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) securities between June 17, 2021 and August 18, 2021, inclusive (the “Class Period”). Nano-X investors have until December 6, 2021 to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Nano-X Imaging Ltd.

LOS ANGELES--(BUSINESS WIRE)---- $NNOX #investors--The Law Offices of Frank R. Cruz Announces Investigation of Nano-X Imaging Ltd. (NNOX) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Nano-X Imaging Ltd.

ATI Physical Therapy

Sesen Bio Inc.

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATIP, SESN and NNOX

LOS ANGELES--(BUSINESS WIRE)---- $nnox #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Nano-X investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities law

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nano-X Imaging Ltd. (NNOX) on Behalf of Investors

San Francisco, California--(Newsfile Corp. - October 13, 2021) - Hagens Berman urges Nano-X Imaging Ltd. (NASDAQ: NNOX) investors with significant losses to submit your losses now.Class Period: June 17, 2021 - Aug. 18, 2021Lead Plaintiff Deadline: Dec. 6, 2021Visit: www.hbsslaw.com/investor-fraud/NNOX Contact An Attorney Now: NNOX@hbsslaw.com 844-916-0895Nano-X Imaging Ltd. (NNOX) Securities Fraud Class Action: Nano-X, a digital X-ray company, is developing the "Nanox.ARC," an imaging system that...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Nano-X Imaging (NNOX) Investors with Losses to Contact Firm's Attorneys Now, Securities Fraud Class Action Pending

BENSALEM, Pa.--(BUSINESS WIRE)---- $NNOX #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) investors concerning the Company's possible violations of federal securities laws. On August 19, 2021, Nano-X revealed that it had “received a request for additional information from the U.S. Food and Drug Administration (the ‘FDA') concerning the Company's last 510(k) submission of its multi-source device, Nanox.ARC.” The 510(k) s

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nano-X Imaging Ltd.

New York, New York--(Newsfile Corp. - October 11, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between June 17, 2021 and August 18, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no...

Rosen, Global Investor Counsel, Encourages Nano-X Imaging Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NNOX

News for Nano-X Imaging Stock (NNOX)